caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1619182946

Uma BorateM.D.

HematologyColumbus, OHI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
325
Unique beneficiaries
—
Total services
563
Distinct HCPCS
8
Medicare payment
$34K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 63 Hematology providers in OH — above median (cohort median 294).
REFERRAL NETWORK

Where Uma Borate's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 11 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
UNIVERSITY OF ALABAMA AT BIRMINGHAM2004,290
University Of Alabama Health Services Foundation, Pc
Clinical Laboratory · Birmingham, AL
2191
NPI 103313849019125
Sushilkumar Sonavane
Diagnostic Radiology · Jacksonville, FL
1773
Kelly Godby
Hematology-Oncology · Birmingham, AL
15283
Suzanne Herrin
Physician Assistant · Birmingham, AL
1557
Amitkumar Mehta
Hematology-Oncology · Birmingham, AL
14329
Ferdinand Urthaler
Cardiology · Birmingham, AL
1336
Laboratory Corporation Of America Holdings
Clinical Laboratory · Birmingham, AL
1145
Vlada Kent
Nurse Practitioner · Birmingham, AL
1135
Jubal Watts
Diagnostic Radiology · Birmingham, AL
1133
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
194
Beneficiaries
—
Total drug cost
$2.5M
Distinct drugs
8
Brand share
100.0%
Top prescribed drugs
Venetoclax72 claims
Ruxolitinib Phosphate32 claims
Dasatinib29 claims
Azacitidine14 claims
Momelotinib Dihydrochloride13 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$57K
Payment records
80
By payment type
Consulting Fee$46K
Travel and Lodging$9K
Food and Beverage$2K